Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-12-19 Purchase |
2023-12-19 8:24 pm |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
20,000 | $2.0524 | $41,048 | 38,459 (Direct) |
View |
2023-06-02 Purchase |
2023-06-06 9:00 pm |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
30,000 | $0.431 | $12,930 | 1,327,174 (Direct) |
View |
2023-06-01 Purchase |
2023-06-02 08:00 am |
180 Life Sciences Corp. | ATNF | STEINMAN LAWRENCE Director |
18,000 | $1.226 | $22,068 | 48,129 (Direct) |
View |
2021-12-09 Purchase |
2021-12-10 08:22 am |
180 Life Sciences Corp. | ATNF | STEINMAN LAWRENCE Director |
5,000 | $4.27 | $21,350 | 627,574 (Direct) |
View |
2021-11-02 Sale |
2021-11-03 5:09 pm |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
450 | $30 | $13,500 | 18,459 (Direct) |
View |
2021-09-15 Sale |
2021-09-17 2:05 pm |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
450 | $36.82 | $16,569 | 18,909 (Direct) |
View |
2021-08-16 Sale |
2021-08-18 5:48 pm |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
450 | $40.6 | $18,270 | 19,359 (Direct) |
View |
2021-07-15 Sale |
2021-07-19 9:25 pm |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
450 | $38.29 | $17,231 | 19,809 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-20 Option Award |
2025-02-21 6:24 pm |
N/A N/A |
180 Life Sciences Corp. | ATNF | STEINMAN LAWRENCE Director |
65,000 | $0 | 67,534 (Direct) |
View |
2024-06-13 Option Award |
2024-06-14 4:15 pm |
N/A N/A |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
16,500 | $0 | 54,959 (Direct) |
View |
2024-03-01 Option Award(A) |
2024-04-05 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
7,500 | $0 | 7,500 (Direct) |
View |
2024-03-01 Option Award |
2024-03-01 9:47 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
7,500 | $0 | 7,500 (Direct) |
View |
2023-09-04 Option Award |
2023-09-06 6:55 pm |
N/A 2033-09-04 |
180 Life Sciences Corp. | ATNF | STEINMAN LAWRENCE Director |
15,000 | $0 | 63,129 (Direct) |
View |
2023-06-14 Option Award |
2023-06-15 6:40 pm |
N/A 2033-06-14 |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
50,000 | $0 | 50,000 (Direct) |
View |
2022-11-28 Option Award |
2022-11-28 4:00 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $0.98 | 1,287,174 (Direct) |
View |
2022-11-22 Option Award |
2022-11-22 4:10 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $0.99 | 1,282,174 (Direct) |
View |
2022-10-26 Option Award |
2022-10-26 5:35 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1.1 | 1,277,174 (Direct) |
View |
2022-10-17 Option Award |
2022-10-17 6:11 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
9,000 | $1.13 | 1,272,174 (Direct) |
View |
2022-10-17 Option Award |
2022-10-17 6:11 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
1,000 | $1.14 | 1,272,174 (Direct) |
View |
2022-06-28 Option Award |
2022-06-30 4:15 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1.02 | 1,272,174 (Direct) |
View |
2022-06-29 Option Award |
2022-06-30 4:15 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1 | 1,272,174 (Direct) |
View |
2022-06-27 Option Award |
2022-06-27 4:15 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1 | 1,262,174 (Direct) |
View |
2022-06-23 Option Award |
2022-06-23 4:31 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1 | 1,257,174 (Direct) |
View |
2021-08-02 Option Award |
2022-06-22 4:30 pm |
2022-08-02 2031-08-02 |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
752,174 | $0 | 1,352,174 (Direct) |
View |
2022-06-16 Option Award |
2022-06-17 7:53 pm |
N/A 2032-06-16 |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-12-08 Option Award |
2021-12-10 08:22 am |
2021-12-08 2031-12-08 |
180 Life Sciences Corp. | ATNF | STEINMAN LAWRENCE Director |
25,000 | $0 | 627,574 (Direct) |
View |
2021-09-30 Option Award |
2021-10-05 08:16 am |
N/A N/A |
180 Life Sciences Corp. | ATNF | STEINMAN LAWRENCE Director |
5,216 | $6 | 597,574 (Direct) |
View |
Ownership |
2021-09-14 9:49 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
0 | $0 | 600,000 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 9:27 pm |
N/A 2031-06-15 |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
12,307 | $0 | 37,954 (Direct) |
View |
2021-06-14 Other |
2021-06-16 9:27 pm |
N/A N/A |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
5,388 | $0 | 37,954 (Direct) |
View |
2021-04-07 Option Award |
2021-04-08 08:00 am |
N/A N/A |
180 Life Sciences Corp. | ATNF | STEINMAN LAWRENCE Director |
22,585 | $6.14 | 592,358 (Direct) |
View |
Ownership |
2020-12-15 7:54 pm |
N/A N/A |
BioAtla Inc. | BCAB | STEINMAN LAWRENCE Director |
0 | $0 | 14,871 (Direct) |
View |
Ownership |
2020-11-12 7:54 pm |
N/A N/A |
180 Life Sciences Corp. | ATNF | STEINMAN LAWRENCE Director |
0 | $0 | 569,773 (Direct) |
View |